“A Novel Bifunctional Hybrid Conjugate of 3-O-Methyl Ellagic Acid and Urolithin A via PEG₃ Linker: In Silico CDK2-Targeted Strategy for Lung Cancer Therapy”, Pjmcr, vol. 5, no. 2, pp. 1193–1200, Apr. 2026, doi: 10.66021/pakmcr914.